ArticlePharmacotherapy2016

Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.

Katrina Wilcox Hagberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.